Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

25
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
25
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

304
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
304
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

392
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
392
Clearance Models: Physiological Models01:09

Clearance Models: Physiological Models

348
Drug clearance is a critical pharmacokinetic process involving the irreversible removal of drugs from the body through various organs over a specified time period. Physiological models are indispensable in determining organ-specific clearance, defined by the proportion of the drug eliminated per unit of time from the organ's blood volume.
The organ's clearance rate depends on the blood flow to the organ and the extraction ratio (E). The extraction ratio describes the organ's...
348
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

372
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
372
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

414
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Frailty Assessment Based on Multidimensional Physical Frailty Parameters Using Unsupervised Clustering in Respiratory Diseases: A Pilot Study.

Journal of clinical medicine·2026
Same author

Comparative analysis of soil prokaryotic community structure and function in Ethiopian Church Forests and adjacent habitats.

Scientific reports·2026
Same author

Optimizing preoperative planning for total hip arthroplasty using random forest models to predict stem size and compatibility.

BMC musculoskeletal disorders·2026
Same author

Heterogeneous pathways to depressive and anxiety disorders: A cluster-based predictive study in a nationwide longitudinal cohort.

Psychological medicine·2026
Same author

Odor-specific olfactory stimulation is associated with selective transcriptional changes and partial improvement of stress-evoked bladder overactivity in mice.

Frontiers in neuroscience·2026
Same author

Creating an engine of scientific discovery, an Indo-Japan perspective: learnings from IJNTC 2025 workshop.

NPJ systems biology and applications·2026

Related Experiment Video

Updated: Feb 20, 2026

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

3.2K

Multilevel modeling of physiological systems on PhysioDesigner

Yoshiyuki Asai, Takeshi Abe, Hiroaki Kitano

    Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica
    |February 11, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    2.3K
    Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
    11:54

    Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

    Published on: May 8, 2021

    5.2K

    Related Experiment Videos

    Last Updated: Feb 20, 2026

    Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
    12:28

    Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

    Published on: June 2, 2023

    3.2K
    In Silico Clinical Trials for Cardiovascular Disease
    09:09

    In Silico Clinical Trials for Cardiovascular Disease

    Published on: May 27, 2022

    2.3K
    Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface
    11:54

    Real-Time Proxy-Control of Re-Parameterized Peripheral Signals using a Close-Loop Interface

    Published on: May 8, 2021

    5.2K